Affluent Medical SAS - Asset Resilience Ratio
Affluent Medical SAS (AFME) has an Asset Resilience Ratio of 0.03% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Affluent Medical SAS working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2024)
This chart shows how Affluent Medical SAS's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is Affluent Medical SAS's balance sheet.
Liquid Assets Composition Over Time
This chart breaks down Affluent Medical SAS's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read AFME current and long-term liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €15.00K | 0.03% |
| Total Liquid Assets | €15.00K | 0.03% |
Asset Resilience Insights
- Limited Liquidity: Affluent Medical SAS maintains only 0.03% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Affluent Medical SAS Industry Peers by Asset Resilience Ratio
Compare Affluent Medical SAS's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Stratec SE
XETRA:SBS |
Medical Devices | 0.29% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
DRTECH Corporation
KQ:214680 |
Medical Devices | 5.18% |
|
Novacyt
PA:ALNOV |
Medical Devices | 0.02% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.48% |
Annual Asset Resilience Ratio for Affluent Medical SAS (2016–2024)
The table below shows the annual Asset Resilience Ratio data for Affluent Medical SAS.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 10.88% | €6.62 Million ≈ $7.74 Million |
€60.86 Million ≈ $71.15 Million |
+7.95pp |
| 2023-12-31 | 2.93% | €1.66 Million ≈ $1.94 Million |
€56.62 Million ≈ $66.20 Million |
-1.31pp |
| 2022-12-31 | 4.24% | €2.54 Million ≈ $2.98 Million |
€60.02 Million ≈ $70.17 Million |
-11.88pp |
| 2021-12-31 | 16.12% | €11.29 Million ≈ $13.20 Million |
€70.03 Million ≈ $81.88 Million |
+7.53pp |
| 2020-12-31 | 8.60% | €5.57 Million ≈ $6.51 Million |
€64.83 Million ≈ $75.79 Million |
+5.34pp |
| 2019-12-31 | 3.26% | €2.13 Million ≈ $2.49 Million |
€65.25 Million ≈ $76.29 Million |
-4.14pp |
| 2017-12-31 | 7.40% | €4.99 Million ≈ $5.83 Million |
€67.39 Million ≈ $78.79 Million |
+4.51pp |
| 2016-12-31 | 2.90% | €1.79 Million ≈ $2.09 Million |
€61.72 Million ≈ $72.16 Million |
-- |
About Affluent Medical SAS
Affluent Medical SA, a medical technology company, develops and markets minimally invasive minimally invasive medical devices in the field of urology and structural heart in France. It offers Artus, an implantable electro-mechanical artificial sphincter that targets moderate to severe urinary incontinence; and Kalios and Epygon implants for the treatment of mitral insufficiency, as well as Kardio… Read more